This second edition, updated with new figures and tables based on Chinese official statistics, provides an overview of the development of the Chinese pharmaceutical industry and its current status, and a discussion of the competitiveness of the Chinese pharmaceutical industry in the international market. The report also provides an analysis of the business opportunities for pharmaceutical firms considering alliances in China, based on this research and the commitments made by Chinese authorities at the time of accession to the WTO, and concludes by highlighting the significant points for consideration for companies looking to capture such business opportunities in China.
The appendices include two case studies that explore examples of a ’Sino-foreign equity joint venture’ and a ’Wholly foreign-owned company’ in China, references, a glossary of terms, the source data used in the figures, and a resources section.
ISBN 0-9545760-5-5
Other selected research from the 'China' category:
Chinese Pharmaceutical Market Overview - Regulatory reform and the evolving healthcare market provide opportunities in china
The Chinese pharmaceutical market, although only positioned ninth globally, has experienced pronounced and rapid expansion in recent years, driven by the growth of both Chinese and Western manufacturers. Increasingly, there is a shift towards a research-based industry, focused on generating new, innovative therapies, supported by improving intellectual property regulations. Learn More
Chinese Pharmaceutical Market 2010-2025
what prospects can you find there?
Our new report will show you how the Chinese pharma market will develop from 2010. You can identify where the greatest opportunities will lie... Learn More
Our new report will show you how the Chinese pharma market will develop from 2010. You can identify where the greatest opportunities will lie... Learn More
Other selected research from the 'Markets' category:
The Global Multiple Sclerosis Market 2009-2024
The multiple sclerosis (MS) market has total global revenues of over $6bn in 2008. Those revenues will exceed $9bn during the second half of next decade, our new study shows. This report will provide you with the analytical information that you need to understand current trends and future directions in the MS market area, the successful drugs being introduced and where the future successful growth of the market lies. Learn More
The Diabetes Market Outlook: Market analysis of future growth and leading players by sector
This report analyzes diabetes market dynamics and provides a country-by-country drug and brand analysis enabling you to assess product success/failure within US and European geographical markets. Learn More